Aller au contenu

A double-blind placebo-controlled randomized phase II trial assessing the activity and safety of regorafenib in non-adipocytic sarcoma patients previously treated with both chemotherapy and pazopanib

Nom du journal : Eur J Cancer

Année : 2020

Volume : 126

Page de départ : 45

Page de fin : 55

Auteurs: Taieb S, Saada-Bouzid E, Wallet J, Brodowicz T, Mir O, Bertucci F, Delcambre C, Salas S, Bompas E, Chaigneau L, Italiano A, Le Deley MC, Penel N, Blay JY, Le Cesne A, Ray-Coquard I, Laroche L, Chevreau C, Decoupigny E, Vanseymortier M,